Learn More
*American College of Cardiology Foundation Representative; †Society for Cardiovascular Angiography and Interventions Representative; ‡American Association for Clinical Chemistry Representative; §American College of Physicians Representative; American College of Emergency Physicians Representative; ¶American College of Chest Physicians Representative; #ACCF(More)
The action description languages B and C have significant common core. Nevertheless, some expressive possibilities of B are difficult or impossible to simulate in C, and the other way around. The main advantage of B is that it allows the user to give Prolog-style recursive definitions, which is important in applications. On the other hand, B solves the(More)
The interventional cardiologist makes a provisional diagnosis of the no-reflow phenomenon in the presence of an acute reduction in coronary flow despite a widely patent epicardial vessel during percutaneous coronary intervention (PCI). Its occurrence is recognized as a column of contrast arising distal to the original target stenosis that does not rapidly(More)
UNLABELLED We compared the effects of 0.125% ropivacaine with 0.125% bupivacaine in laboring patients using patient-controlled epidural analgesia (PCEA). Fifty-one ASA physical status I or II term parturients with functioning epidural catheters were randomized to receive ropivacaine or bupivacaine using a prospective, double-blind design. Basal infusions (6(More)
Action languages are formal models of parts of natural language that are designed to describe effects of actions. Many of these languages can be viewed as high level notations of answer set programs structured to represent transition systems. However, the form of answer set programs considered in the earlier work is quite limited in comparison with the(More)
BACKGROUND The Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial randomized 3,339 patients to either an invasive (INV, n = 1,681) or a conservative (CON, n = 1,658) strategy after intravenous recombinant tissue-type plasminogen activator (rt-PA) for acute myocardial infarction. METHODS AND RESULTS The patients assigned to the INV strategy(More)
CONTEXT Despite 2 decades of evidence demonstrating benefits from prompt coronary reperfusion, registries continue to show that many patients with ST-segment elevation myocardial infarction (STEMI) are treated too slowly or not at all. OBJECTIVE To establish a statewide system for reperfusion, as exists for trauma care, to overcome systematic barriers. (More)